Difference between revisions of "BCG vaccine"
| Line 10: | Line 10: | ||
==Patient drug information== | ==Patient drug information== | ||
| − | *[https://www.fda.gov/media/76396/download Editing Bacillus Calmette-Guérin (BCG) package insert] | + | *[https://www.fda.gov/media/76396/download Editing Bacillus Calmette-Guérin (BCG) package insert] |
*[http://chemocare.com/chemotherapy/drug-info/bcg.aspx Bacillus Calmette-Guérin (BCG) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/bcg.aspx Bacillus Calmette-Guérin (BCG) patient information (Chemocare)]</ref> | *[http://chemocare.com/chemotherapy/drug-info/bcg.aspx Bacillus Calmette-Guérin (BCG) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/bcg.aspx Bacillus Calmette-Guérin (BCG) patient information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/patient-information-bladder-cancer-treatment-non-muscle-invasive-superficial-cancer Patient information about bladder cancer treatment, including BCG (UpToDate)]<ref>[http://www.uptodate.com/contents/patient-information-bladder-cancer-treatment-non-muscle-invasive-superficial-cancer Patient information about bladder cancer treatment, including BCG (UpToDate)]</ref> | *[http://www.uptodate.com/contents/patient-information-bladder-cancer-treatment-non-muscle-invasive-superficial-cancer Patient information about bladder cancer treatment, including BCG (UpToDate)]<ref>[http://www.uptodate.com/contents/patient-information-bladder-cancer-treatment-non-muscle-invasive-superficial-cancer Patient information about bladder cancer treatment, including BCG (UpToDate)]</ref> | ||
Revision as of 10:01, 4 April 2021
General information
Class/mechanism: Live mycobacteria which promote a local acute inflammatory and sub-acute granulomatous reaction with macrophage and leukocyte infiltration in the urothelium and lamina propria of the urinary bladder. This results in a likely T-lymphocyte dependent anti-tumor effect.[1][2]
Route: Intravesicular
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Bladder cancer (intravesicular use)
Patient drug information
- Editing Bacillus Calmette-Guérin (BCG) package insert
- Bacillus Calmette-Guérin (BCG) patient drug information (Chemocare)[3]
- Patient information about bladder cancer treatment, including BCG (UpToDate)[4]
Also known as
- Generic name: Bacille Calmette–Guérin
- Brand names: TheraCys, TICE BCG